Robert Roswell Chai-Onn, EVP, GC & Corporate Secretary at Valeant Pharmaceuticals International, Inc. (VRX), sold 35,607 shares at $25.95 ($924K) on 2010-11-09, disclosed to the SEC on 2010-11-12.
Scheduled sale ($924k) by EVP, GC & Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRX | SELL | 2014-06-24 | $1.2M | — | Filing → |
| VRX | SELL | 2014-05-14 | $1.3M | — | Filing → |
| VRX | SELL | 2014-03-19 | $709K | — | Filing → |